fda glp-1 warning letters october 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA Drug Recalls and Warnings:

Similarities Between GLP-1 and Semaglutide Despite their differences, GLP-1 and semaglutide share important functional similarities: Same receptor target: Both natural GLP-1 and semaglutide act on GLP-1 receptors throughout the body

Incretin-based therapies have been associated with a body weight (BW) reduction of 5% in at least half of patients in most randomized controlled trials (RCT) and real-world studies (RWS)

Nurse-practitioner networks widen access in lower-cost settings, while asynchronous prescribing platforms support simpler cases

This reduced glutathione powder is enhanced for better absorption and effective daily use

Addressing these metabolic disruptions could lead to the development of more effective therapeutic strategies for managing ME/CFS, GWS, and FM